MOUNJARO Trademark

Trademark Overview

On Tuesday, November 5, 2019, a trademark application was filed for MOUNJARO with the United States Patent and Trademark Office. The USPTO has given the MOUNJARO trademark a serial number of 88680946. The federal status of this trademark filing is REGISTERED as of Tuesday, August 2, 2022. This trademark is owned by Eli Lilly and Company. The MOUNJARO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diabetes
mounjaro

General Information

Serial Number88680946
Word MarkMOUNJARO
Filing DateTuesday, November 5, 2019
Status700 - REGISTERED
Status DateTuesday, August 2, 2022
Registration Number6809369
Registration DateTuesday, August 2, 2022
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 3, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diabetes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 13, 2019
Primary Code005
First Use Anywhere DateFriday, June 3, 2022
First Use In Commerce DateFriday, June 3, 2022

Trademark Owner History

Party NameEli Lilly and Company
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285
Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285
Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events

Event DateEvent Description
Friday, November 8, 2019NEW APPLICATION ENTERED
Thursday, January 16, 2020ASSIGNED TO EXAMINER
Wednesday, November 13, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 24, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 12, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 3, 2020PUBLISHED FOR OPPOSITION
Tuesday, March 3, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 28, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 22, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, September 22, 2020SOU EXTENSION 1 FILED
Tuesday, September 29, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, October 8, 2020SOU EXTENSION 1 GRANTED
Friday, October 9, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 20, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 31, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, March 31, 2021SOU EXTENSION 2 FILED
Wednesday, March 31, 2021SOU EXTENSION 2 GRANTED
Friday, April 2, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 18, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, August 18, 2021SOU EXTENSION 3 FILED
Wednesday, August 18, 2021SOU EXTENSION 3 GRANTED
Wednesday, March 16, 2022SOU EXTENSION 4 FILED
Wednesday, March 16, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, April 12, 2022SOU EXTENSION 4 GRANTED
Wednesday, April 13, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 10, 2022TEAS STATEMENT OF USE RECEIVED
Friday, June 10, 2022USE AMENDMENT FILED
Tuesday, June 28, 2022STATEMENT OF USE PROCESSING COMPLETE
Tuesday, June 28, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, June 29, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, August 2, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, August 2, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Monday, December 4, 2023NOTICE OF SUIT
Thursday, August 1, 2024NOTICE OF SUIT
Thursday, July 18, 2024NOTICE OF SUIT

Related Keywords

mounjaro pharmaceutical preparations diabetes namely treatment